# Modulation of Gut Microbiota in End-stage Renal Disease

> **NCT02568891** · NA · WITHDRAWN · sponsor: **Medical University of Graz**

## Conditions studied

- End-stage Renal Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02568891
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-01
- **Primary completion:** 2020-01
- **Final completion:** 2021-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No funding obtained
- **Last updated:** 2017-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02568891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02568891, "Modulation of Gut Microbiota in End-stage Renal Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02568891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*